Medicare Enrolled
Dr. Khamaj Dave, MD
Interventional Cardiology · Oxnard, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dave from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dave?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dave
Dr. Khamaj Dave is an interventional cardiology specialist in Oxnard, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dave performed 7,047 Medicare services across 3,229 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dave received a total of $6,787 from 33 pharmaceutical and/or device companies across 335 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dave is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 15% volume in CA
$6,787 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,047
Medicare services
Top 15% in CA for interventional cardiology
3,229
Unique beneficiaries
$81
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~352 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,107 | $141 | $300 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
984 | $40 | $111 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
873 | $34 | $94 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
612 | $43 | $124 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
527 | $54 | $144 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
372 | $47 | $119 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
339 | $12 | $66 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
297 | $103 | $175 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
261 | $20 | $45 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
216 | $45 | $88 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
214 | $18 | $65 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
160 | $168 | $930 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
149 | $21 | $85 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
128 | $23 | $90 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
106 | $21 | $80 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 102 | $417 | $1,000 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
76 | $210 | $998 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
72 | $45 | $220 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
72 | $21 | $230 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
58 | $62 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
54 | $61 | $373 |
| New patient office visit, complex (60-74 min) | 44 | $172 | $380 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
35 | $65 | $140 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
34 | $1,747 | $3,500 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
34 | $124 | $400 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
20 | $11 | $35 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
20 | $20 | $60 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $22 | $75 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
18 | $804 | $1,500 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
17 | $1,360 | $4,000 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
16 | $179 | $570 |
| Wearable defibrillator system evaluation Assessment of a wearable cardioverter defibrillator to ensure proper function and fit. |
12 | $47 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
6.9% medium
87.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,787
Total received (2018-2024)
Avg $970/year across 7 years
Top 49% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
335
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,787 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$42
2023
$177
2022
$286
2021
$361
2020
$727
2019
$2,895
2018
$2,300
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$24
SCPHARMACEUTICALS INC.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
ABIOMED
$927
Amgen Inc.
$642
Actelion Pharmaceuticals US, Inc.
$632
AstraZeneca Pharmaceuticals LP
$595
Novartis Pharmaceuticals Corporation
$493
SANOFI-AVENTIS U.S. LLC
$370
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$343
Janssen Pharmaceuticals, Inc
$317
Gilead Sciences, Inc.
$315
Abbott Laboratories
$244
PFIZER INC.
$207
Medtronic Vascular, Inc.
$193
Boston Scientific Corporation
$177
Amarin Pharma Inc.
$175
Acist Medical Systems, Inc.
$167
E.R. Squibb & Sons, L.L.C.
$164
Otsuka America Pharmaceutical, Inc.
$127
Regeneron Healthcare Solutions, Inc.
$124
Boehringer Ingelheim Pharmaceuticals, Inc.
$114
Allergan Inc.
$81
Baxter Healthcare
$77
Medtronic, Inc.
$60
Lundbeck LLC
$49
Philips Electronics North America Corporation
$40
Bardy Diagnostics, Inc.
$25
Novo Nordisk Inc
$24
AngioDynamics, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
SCPHARMACEUTICALS INC.
$18
ARBOR PHARMACEUTICALS, INC.
$17
Relypsa, Inc.
$15
Kowa Pharmaceuticals America, Inc.
$13
Cardiovascular Systems Inc.
$5
Top 3 companies account for 32.4% of all-time payments
Associated products mentioned in payments ›
(6571) Eagle Eye · AVEIR · Adempas · BRILINTA · BYSTOLIC · CHANTIX · COREVALVE EVOLUT R · Carnation Ambulatory Monitor · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FUROSCIX · HD-IVUS · Hillrom - Cardiac Ambulatory Monitor · Impella · JARDIANCE · LifeVest · Livalo · MULTAQ · Micra · Mitra Clip system · MitraClip System · NORTHERA · OPSUMIT · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · Reveal LINQ · Reveal XT · SAMSCA · UPTRAVI · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Interventional cardiologists within 10 mi
9
Per 100K population
1.1
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dave is a clinical cardiology specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dave experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Dave performed 1,107 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dave receive payments from pharmaceutical companies?
Yes. Dr. Dave received a total of $6,787 from 33 companies across 335 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dave's costs compare to other interventional cardiologists in Oxnard?
Dr. Dave's average Medicare payment per service is $81. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dave) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Oxnard
Browse interventional cardiologists in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology